Hybrid closed-loop systems (HCLSs) aid in the management of hyperglycemia and the reduction in hypoglycemia by automatically adjusting insulin infusion based on real-time continuous glucose sensor readings and predictive algorithms. The gene discussed is INS; the disease is Hyperglycemia.